Strategies to Reduce Contrast Medium in Spectral CT Pulmonary Angiography
Pulmonary Embolism
About this trial
This is an interventional diagnostic trial for Pulmonary Embolism focused on measuring Pulmonary Embolism, Spectral Detector CT, Contrast medium
Eligibility Criteria
Inclusion Criteria:
- Inpatients and outpatients with kidney function (eGFR) allowing for safe administration of contrast dose (as calculated with the OmniVis calculator).
- Patients with clinical suspicion of disease of PE
- Referral to CTPA diagnosis, treatment planning or follow-up.
- Peripheral venous catheter (PVC) =/< 18 G
Exclusion Criteria:
- Contraindication to iodinated contrast medium
- Age < 18 years
- Lack of informed consent
- Pregnancy
Sites / Locations
- Akershus University Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Low concentration
Low volume
Saline Dilution
Patients receive a contrast medium with an iodine concentration of 140 mg/ml. The volume is 1 ml/kg which result in a dose of 140 mg/kg. Maximal dose of contrast medium is 90 ml i.e. 12.6 g of iodine.
Patients receive a contrast medium with an iodine concentration 350 of mg/ml. The volume is 0.4 ml/kg which result in a dose of 140 mg/kg. Maximal dose of contrast medium is 36 ml i.e. 12.6 g of iodine.
Patients receive a contrast medium with an iodine concentration of 350 mg/ml. The contrast medium is diluted 1:1 with saline. The injected volume is 0.8 ml/kg which result in a dose of 140 mg/kg. Maximal dose of contrast medium is 72 ml i.e. 12.6 g of iodine.